Citigroup’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Sell |
85,456
-32,825
| -28% | -$181K | ﹤0.01% | 2964 |
|
|
2025
Q1 | $682K | Buy |
118,281
+2,528
| +2% | +$14.6K | ﹤0.01% | 2786 |
|
|
2024
Q4 | $1.07M | Buy |
+115,753
| New | +$1.07M | ﹤0.01% | 2554 |
|
|
2022
Q4 | – | Sell |
-27
| Closed | -$1K | – | 5012 |
|
|
2022
Q3 | $1K | Sell |
27
-8
| -23% | -$296 | ﹤0.01% | 4827 |
|
|
2022
Q2 | $2K | Sell |
35
-15
| -30% | -$857 | ﹤0.01% | 5102 |
|
|
2022
Q1 | $3K | Sell |
50
-20
| -29% | -$1.2K | ﹤0.01% | 5145 |
|
|
2021
Q4 | $5K | Sell |
70
-52
| -43% | -$3.71K | ﹤0.01% | 4880 |
|
|
2021
Q3 | $10K | Sell |
122
-27
| -18% | -$2.21K | ﹤0.01% | 4710 |
|
|
2021
Q2 | $14K | Sell |
149
-266
| -64% | -$25K | ﹤0.01% | 4828 |
|
|
2021
Q1 | $50K | Sell |
415
-294
| -41% | -$35.4K | ﹤0.01% | 4052 |
|
|
2020
Q4 | $93K | Buy |
709
+603
| +569% | +$79.1K | ﹤0.01% | 3723 |
|
|
2020
Q3 | $12K | Sell |
106
-396
| -79% | -$44.8K | ﹤0.01% | 4215 |
|
|
2020
Q2 | $130K | Sell |
502
-202
| -29% | -$52.3K | ﹤0.01% | 3302 |
|
|
2020
Q1 | $314K | Sell |
704
-62
| -8% | -$27.7K | ﹤0.01% | 2575 |
|
|
2019
Q4 | $518K | Buy |
766
+754
| +6,283% | +$510K | ﹤0.01% | 2611 |
|
|
2019
Q3 | $4K | Sell |
12
-55
| -82% | -$18.3K | ﹤0.01% | 4842 |
|
|
2019
Q2 | $12K | Buy |
+67
| New | +$12K | ﹤0.01% | 4712 |
|